前收市價 | 1.6000 |
開市 | 1.6000 |
買盤 | 0.0000 |
賣出價 | 0.0000 |
拍板 | 2.50 |
到期日 | 2024-05-17 |
今日波幅 | 1.6000 - 1.6000 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 無 |
Fate Therapeutics (FATE) delivered earnings and revenue surprises of 0% and 140.63%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Fate Therapeutics (FATE) gains 86.4% on encouraging pipeline progress of its cellular immunotherapies for cancer.
Amicus Therapeutics (FOLD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.